Abstract 2192: Potential of galectin-7 as differentiating biomarker of lung cancer subtypes
Avery Funkhouser(National Institutes of Health), Anna V. Blenda(University of South Carolina), Alexandra E. Kesic(Prisma Health), Connie M. Arthur(Emory University), Christopher Ronald Funk(Emory University), Julie Martin(Prisma Health), Jonah C. Shealy(University of South Carolina), Bailey B. Blair(University of South Carolina), William J. Edenfield(Prisma Health)
Cited by 0
Related Papers
Dimeric Galectin-8 Induces Phosphatidylserine Exposure in Leukocytes through Polylactosamine Recognition by the C-terminal Domain
|Journal of Biological Chemistry|2008|144
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
|Journal for ImmunoTherapy of Cancer|2020|117
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
|Cancers|2021|36
Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis
|Current Issues in Molecular Biology|2021|33